- Broad specialty product assortment addresses a range of customer and consumer needs
- New service tools for even closer collaboration with customers
- Jointly developed product novelties demonstrate successful integration of recently acquired companies
Evonik will present an expanded product portfolio, new technologies and innovative service tools at in-cosmetics Global 2019 in Paris. The company’s growing product portfolio is the result of in-house research and several successful acquisitions.
“We gained three powerful mainstays with Evonik Dr. Straetmans, Evonik Delivery Systems and Evonik Advanced Botanicals in recent years. I am pleased to present a much more well-rounded product portfolio to our customers than ever before,” says Dr. Tammo Boinowitz, the head of the Care Solutions business line. “It is not only proof of successful integration, but also highlights the customer benefits generated by our broad range of high-quality ingredients, biological process expertise, and market knowledge.”
Evonik’s exhibit will be set up at Stand H 30 of the Paris tradeshow. Among other offers, the Care Solutions business line will present the natural cosmetic ingredient NeoPlanta® Withania. This powerful, multifunctional active ingredient protects the skin against premature aging caused by stress and environmental influences. Evonik Advanced Botanicals produces the extract from the roots of the Ayurvedic ashwagandha plant through a biotechnological cultivation process. NeoPlanta® Withania is the first product to be jointly developed by the experts from Evonik Care Solutions and Evonik Advanced Botanicals.
The tetrapeptide TEGO® Pep UP protects the skin against the damaging blue light emitted by laptop, smartphone or tablet screens. Consumers are increasingly looking for products to counteract these effects. As an added benefit, TEGO® Pep UP also supports the regeneration of the affected skin areas. The tetrapeptide increases the production of collagen and other fibrous proteins in the skin's extracellular matrix to achieve a lifting effect.
Evonik Dr. Straetmans became a part of Care Solutions in 2017. In Paris, the experts for alternative preservative solutions will present two antioxidants to improve oxidation protection: dermofeel® TocoBalance contains a mixture of natural tocopherols from rapekernel oil that effectively protects both the skin and the oxidizable components of cosmetic formulations. dermofeel® TocoSkin, made from natural sunflower oil, is particularly rich in alpha-tocopherols that offer effective skin protection against oxidative stress. Both antioxidants are suitable for use in certified natural cosmetics.
The exhibit in Paris will also present the new intoBeauty® online platform, in which the company has arranged all relevant information on its products and formulation concepts in a central place. In addition to product information and documentation, users can access online videos and digital tools such as the Sensory Kaleidoscope and the Ceramide Knowledge Center around the clock by logging into intobeauty.evonik.com.
Evonik has long been committed to the sustainability of its products. With its CAREtain® Toolbox, the company is now offering its customers a dynamic, continuously growing information system that covers the most relevant sustainability aspects, with categories including RSPO-certified, biodegradable, COSMOS status, vegan and place of origin. Evonik's CAREtain® Toolbox creates transparency, makes the company’s sustainability philosophy tangible, and provides customers with an instrument to develop their own, ecologically optimized products. The Toolbox is also accessible through the intobeauty.evonik.com portal.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 36,000 employees. In fiscal 2018, the enterprise generated sales of €15 billion and an operating profit (adjusted EBITDA) of €2.6 billion.
Evonik’s international activities are organized into six regions. The Asia Pacific North region is headquartered in Shanghai. Sales in Asia Pacific North reached €2,276 million in 2018. Evonik regards China as one of the driving forces of the global economy and we consequently endeavor to grow our business here. The company now employs about 3,000 employees and has in total of 10 production sites in China.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.